Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Native ads
Contact us
Menu
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Native ads
Contact us
EN
SV
Investor letters
2023
Investor letter October 2
Investor letter July 28
Investor letter July 25
Investor letter July 19 (in Swedish)
2022 (only in Swedish)
Viktiga nyanställningar säkerställer fortsatt utvecklingsarbete av Psyros POC-plattform
Två bolag blir en koncern, med unika, patentsökta tekniker och oerhört kompetent personal
Välmeriterat och kompetent team stärker Prolight Diagnostics ytterligare
